PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro - Finn, R S; Dering, J; Conklin, D (Breast Cancer Res, 2009)
et al.